Literature DB >> 21133708

Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function.

Antonio Lucio Teixeira1, Izabela Guimarães Barbosa, Breno Satler Diniz, Arthur Kummer.   

Abstract

Brain-derived neurotrophic factor (BDNF) is the most widely distributed neurotrophin in the CNS, where it plays several pivotal roles in synaptic plasticity and neuronal survival. As a consequence, BDNF has become a key target in the physiopathology of several neurological and psychiatric diseases. Recent studies have consistently reported altered levels of BDNF in the circulation (i.e., serum or plasma) of patients with major depression, bipolar disorder, Alzheimer's disease, Huntington's disease and Parkinson's disease. Correlations between serum BDNF levels and affective, cognitive and motor symptoms have also been described. BDNF appears to be an unspecific biomarker of neuropsychiatric disorders characterized by neurodegenerative changes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21133708     DOI: 10.2217/bmm.10.111

Source DB:  PubMed          Journal:  Biomark Med        ISSN: 1752-0363            Impact factor:   2.851


  53 in total

1.  Treatment Emergent Suicidal Ideation in depressed older adults.

Authors:  Pilar Cristancho; Brendan O'Connor; Eric J Lenze; Daniel M Blumberger; Charles F Reynolds; David Dixon; Benoit H Mulsant
Journal:  Int J Geriatr Psychiatry       Date:  2016-05-09       Impact factor: 3.485

Review 2.  Genetic Modulation of Neurocognitive Development in Cancer Patients throughout the Lifespan: a Systematic Review.

Authors:  Charlotte Sleurs; Aline Madoe; Lieven Lagae; Sandra Jacobs; Sabine Deprez; Jurgen Lemiere; Anne Uyttebroeck
Journal:  Neuropsychol Rev       Date:  2019-03-30       Impact factor: 7.444

3.  TNFR1 absence protects against memory deficit induced by sepsis possibly through over-expression of hippocampal BDNF.

Authors:  Allan C Calsavara; Frederico M Soriani; Leda Q Vieira; Priscila A Costa; Milene A Rachid; Antônio L Teixeira; Antônio L Teixiera
Journal:  Metab Brain Dis       Date:  2014-08-23       Impact factor: 3.584

4.  Walking speed decline in older adults is associated with elevated pro-BDNF in plasma extracellular vesicles.

Authors:  Caitlin N Suire; Erez Eitan; Nancy Chiles Shaffer; Qu Tian; Stephanie Studenski; Mark P Mattson; Dimitrios Kapogiannis
Journal:  Exp Gerontol       Date:  2017-08-23       Impact factor: 4.032

5.  Rapid antidepressant changes with sleep deprivation in major depressive disorder are associated with changes in vascular endothelial growth factor (VEGF): a pilot study.

Authors:  Lobna Ibrahim; Wallace Duncan; David A Luckenbaugh; Peixiong Yuan; Rodrigo Machado-Vieira; Carlos A Zarate
Journal:  Brain Res Bull       Date:  2011-06-16       Impact factor: 4.077

Review 6.  Measuring myokines with cardiovascular functions: pre-analytical variables affecting the analytical output.

Authors:  Giovanni Lombardi; Veronica Sansoni; Giuseppe Banfi
Journal:  Ann Transl Med       Date:  2017-08

Review 7.  Cognitive impairment in Huntington disease: diagnosis and treatment.

Authors:  Jane S Paulsen
Journal:  Curr Neurol Neurosci Rep       Date:  2011-10       Impact factor: 5.081

8.  Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease.

Authors:  Orestes Vicente Forlenza; Breno Satler Diniz; Antonio Lucio Teixeira; Marcia Radanovic; Leda Leme Talib; Natalia Pessoa Rocha; Wagner Farid Gattaz
Journal:  Neuromolecular Med       Date:  2015-07-03       Impact factor: 3.843

9.  Cortical Amyloid β Deposition and Current Depressive Symptoms in Alzheimer Disease and Mild Cognitive Impairment.

Authors:  Jun Ku Chung; Eric Plitman; Shinichiro Nakajima; M Mallar Chakravarty; Fernando Caravaggio; Philip Gerretsen; Yusuke Iwata; Ariel Graff-Guerrero
Journal:  J Geriatr Psychiatry Neurol       Date:  2015-09-23       Impact factor: 2.680

10.  Brain-derived neurotrophic factor levels in late-life depression and comorbid mild cognitive impairment: a longitudinal study.

Authors:  Breno Satler Diniz; Charles F Reynolds; Amy Begley; Mary Amanda Dew; Stewart J Anderson; Francis Lotrich; Kirk I Erickson; Oscar Lopez; Howard Aizenstein; Etienne L Sibille; Meryl A Butters
Journal:  J Psychiatr Res       Date:  2013-11-20       Impact factor: 4.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.